Atossa Genetics is a clinical-stage pharmaceutical company focused on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.
Atossa Genetics Announces Reverse Stock Split
Atossa Genetics Announces Second Quarter 2016 Financial Results and Provides Company Update
Atossa Genetics to Provide Company Update and Discuss Second Quarter Financial Results on Conference Call on Monday, August 15, 2016
More Press Releases
Learn more about Atossa Genetics
Learn more about our programs
Contact Atossa Genetics today!